Genor Biopharma

IPO

Genor Biopharma is a biotech company in Shanghai, China, founded in 2007. It has raised $160.0M across 1 round, most recently a $160.0M Series B in June 2020.

Headquarters
Shanghai, Shanghai
Employees
201–500
Founded
2007
Business Model
B2B
Total Funding
$160.0M
Last Round
$160.0M Series BJun 2020
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Founded in 2007, Genor Biopharma Co. Ltd. (stock code: 6998.HK) is an innovation-driven biopharma company with a pipeline of therapies covering the world's most prevalent cancer types, including breast, lung, and gastrointestinal cancer, as well as hematological malignancies. The Shanghai-headquartered company develops and commercializes oncology and autoimmune drugs through an integrated platform spanning innovative drug R&D, preclinical research, clinical development, regulatory, and CMC. Genor operates research hubs in Shanghai and San Francisco and commercial-scale manufacturing in Yuxi, Yunnan, targeting patients in China and globally.

Summary

It lists 201–500 employees. It has raised $160.0M in total across 1 round, most recently a $160.0M Series B round in Jun 2020. Investors include Hillhouse Capital, Temasek and CR-CP Life Science Fund.

Funding & Exit History

Data from Indexed.vcUpdated
IPOOct 2020
$372.0M

Sign up to see all 2 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genor Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/genor-biopharma"><img src="https://indexed.vc/api/badge/company/genor-biopharma" alt="Genor Biopharma on Indexed.vc" width="260" height="76" /></a>